Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Chengyu Yang, Li Yang, Lei Yang, Shuiming Li, Ling Ye, Jinfeng Ye, Chengshui Chen, Yiming Zeng, Mengchan Zhu, Xiaoping Lin, Qing Peng, Yun Wang & Meiling Jin. (2023) Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1713-1728.
Read now
Read now
Enrico de Nigris, John Haughney, Amanda J. Lee, Mintu Nath, Hana Müllerová, Ulf Holmgren & Bo Ding. (2023) Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK). COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 92-100.
Read now
Read now
Guohua Lin, Jiaqi Zheng, Pou Kuan Tang, Yu Zheng, Hao Hu & Carolina Oi Lam Ung. (2022) Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2757-2788.
Read now
Read now
Gema Requena, Victoria Banks, Alexandrosz Czira, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022) Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1781-1795.
Read now
Read now
Kjell Larsson, Ann Ekberg-Jansson, Caroline Stridsman, Malin Hanno & Lowie E G W Vanfleteren. (2021) Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 909-918.
Read now
Read now
Ike Iheanacho, Shiyuan Zhang, Denise King, Maria Rizzo & Afisi S Ismaila. (2020) Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 439-460.
Read now
Read now
Johanna Sulku, Christer Janson, Håkan Melhus, Andrei Malinovschi, Björn Ställberg, Kristina Bröms, Marieann Högman, Karin Lisspers, Margareta Hammarlund-Udenaes & Elisabet I Nielsen. (2019) A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2451-2460.
Read now
Read now
Chris Kiff, Sandrine Ruiz, Nebibe Varol, Danny Gibson, Andrew Davies & Debasree Purkayastha. (2018) Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2707-2720.
Read now
Read now
Evie Merinopoulou, Mireia Raluy-Callado, Sreeram Ramagopalan, Sharon MacLachlan & Javaria Mona Khalid. (2016) COPD exacerbations by disease severity in England. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 697-709.
Read now
Read now
Yu-Feng Wei, Ping-Hung Kuo, Ying-Huang Tsai, Chi-Wei Tao, Shih-Lung Cheng, Chao-Hsien Lee, Yao-Kuang Wu, Ning-Hung Chen, Wu-Huei Hsu, Jeng-Yuan Hsu, Ming-Shian Lin & Chin-Chou Wang. (2015) Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1951-1956.
Read now
Read now
Mireia Raluy-Callado, Dimitra Lambrelli, Sharon MacLachlan & Javaria Mona Khalid. (2015) Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 925-937.
Read now
Read now
Articles from other publishers (1)
Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson & Brian T. Maurer. (2020) A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Respiratory Research 21:1.
Crossref
Crossref